hels! What Up? Meeting is MAY 2.
May comes after April!
Ok, kidding aside. Me I'VE JUNKED SOME BABY BIOS into this speculative run up frankly just happy to be rid of them. ACOR is of more substantial heft and I like the fact that they are targeting the MS crowd. If you have MS you have trouble walking and here's where ACOR comes to the rescue. On the market by 09 and $120 million in sales by 2011.
Already have one product on the market! So they know how to sheared through the FDA process-
Zanaflex treats muscle spasm. $35 mill a year this helps defray R&D costs and liquidation to shareholders through secondariness.
So on May 2 they release NEW results further Phase 3 (2nd trial) Piper Jaff Target is $30.
I'm betting we get close to that by then!
~stoney
May comes after April!
Ok, kidding aside. Me I'VE JUNKED SOME BABY BIOS into this speculative run up frankly just happy to be rid of them. ACOR is of more substantial heft and I like the fact that they are targeting the MS crowd. If you have MS you have trouble walking and here's where ACOR comes to the rescue. On the market by 09 and $120 million in sales by 2011.
Already have one product on the market! So they know how to sheared through the FDA process-
Zanaflex treats muscle spasm. $35 mill a year this helps defray R&D costs and liquidation to shareholders through secondariness.
So on May 2 they release NEW results further Phase 3 (2nd trial) Piper Jaff Target is $30.
I'm betting we get close to that by then!
~stoney
.
. Did you buy it?